$CLRI Income Statement | Understand Stock

$CLRI

$0.01 +$0.00 (59.32%) Close

Financial Statements

In USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
Revenue
Cost of Revenue
Gross Profit
Operating Expenses:
Selling expenses
Administrative expenses
Depreciation and amortization expense
Research and development
Total Operating Expenses
Gain on the settlement of accounts payable
Gain on forgiveness of PPP loan
Interest expense, net
Note and interest receivable - related party write off
Interest income/expense, net

Total Other Income/(Expenses)
Loss before income taxes
Provision for income taxes from continuing operations
Income from continuing operations
Net Income
Net (loss)
Preferred stock dividends Series A Preferred
Net (loss) attributable to common stockholders
Net income per common share - basic (in Dollars per share)
Net income per common share - diluted (in Dollars per share)
Net (loss) per common share - basic
Net (loss) per common share - diluted
Weighted Average of number of shares outstanding basic
Weighted Average of number of shares outstanding diluted

Comments